Your browser doesn't support javascript.
loading
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers.
Lee, Soo-Chin; Shimasaki, Noriko; Lim, Joline S J; Wong, Andrea; Yadav, Kritika; Yong, Wei Peng; Tan, Lip Kun; Koh, Liang Piu; Poon, Michelle L M; Tan, Sing Huang; Ow, Samuel G W; Bharwani, Lavina; Yap, Yoon Sim; Foo, Mabel Z Q; Coustan-Smith, Elaine; Sundar, Raghav; Tan, Hon Lyn; Chong, Wan Qin; Kumarakulasinghe, Nesaretnam Barr; Lieow, Jedidah L M; Koe, Priscillia J X; Goh, Boon Cher; Campana, Dario.
Afiliación
  • Lee SC; Department of Hematology-Oncology, National University Cancer Institute, Singapore. csilsc@nus.edu.sg.
  • Shimasaki N; Experimental Therapeutics Programme, Cancer Science Institute, Singapore.
  • Lim JSJ; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Wong A; Department of Hematology-Oncology, National University Cancer Institute, Singapore.
  • Yadav K; Experimental Therapeutics Programme, Cancer Science Institute, Singapore.
  • Yong WP; Department of Hematology-Oncology, National University Cancer Institute, Singapore.
  • Tan LK; Experimental Therapeutics Programme, Cancer Science Institute, Singapore.
  • Koh LP; Experimental Therapeutics Programme, Cancer Science Institute, Singapore.
  • Poon MLM; Department of Hematology-Oncology, National University Cancer Institute, Singapore.
  • Tan SH; Experimental Therapeutics Programme, Cancer Science Institute, Singapore.
  • Ow SGW; Department of Hematology-Oncology, National University Cancer Institute, Singapore.
  • Bharwani L; Department of Hematology-Oncology, National University Cancer Institute, Singapore.
  • Yap YS; Department of Hematology-Oncology, National University Cancer Institute, Singapore.
  • Foo MZQ; Oncocare Cancer Centre, Singapore.
  • Coustan-Smith E; Department of Hematology-Oncology, National University Cancer Institute, Singapore.
  • Sundar R; Department of Medical Oncology, Tan Tock Seng Hospital, Singapore.
  • Tan HL; Department of Medical Oncology, National Cancer Centre, Singapore.
  • Chong WQ; Experimental Therapeutics Programme, Cancer Science Institute, Singapore.
  • Kumarakulasinghe NB; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Lieow JLM; Department of Hematology-Oncology, National University Cancer Institute, Singapore.
  • Koe PJX; Department of Hematology-Oncology, National University Cancer Institute, Singapore.
  • Goh BC; Department of Hematology-Oncology, National University Cancer Institute, Singapore.
  • Campana D; Department of Hematology-Oncology, National University Cancer Institute, Singapore.
Clin Cancer Res ; 26(17): 4494-4502, 2020 09 01.
Article en En | MEDLINE | ID: mdl-32522887
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias de la Mama / Células Asesinas Naturales / Receptor ErbB-2 / Trastuzumab / Inmunoterapia Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Singapur
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias de la Mama / Células Asesinas Naturales / Receptor ErbB-2 / Trastuzumab / Inmunoterapia Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Singapur